Achieving Better Outcomes through Deprescribing
Hours: 1.25
Polypharmacy is an issue for all patients over the age of 65 that escalates during end of life when patients are prescribed both maintenance medications for chronic disease states and symptom management medications. Upon admission to hospice, our pharmacy call center profiles at least 20 medications for each patient of which one-third are of questionable benefit to a patient at end of life. CMS continues to struggle with the high percentage of medications still being billed through Medicare Part D for patients on the hospice benefit. Discontinuing non-beneficial medications at end of life has proven to improve patient comfort and quality of life via data published in recent literature. Hospice clinicians can make an impact by framing medication discontinuation discussions therapeutically, clarifying that stopping or adjusting meds is done to prevent harm and promote patient well-being and time them on hospice admission, during changes in level of care and/or when a trust relationship is formed to ease transition.
Polypharmacy is an issue for all patients over the age of 65 that escalates during end of life when patients are prescribed both maintenance medications for chronic disease states and symptom management medications. Upon admission to hospice, our pharmacy call center profiles at least 20 medications for each patient of which one-third are of questionable benefit to a patient at end of life. CMS continues to struggle with the high percentage of medications still being billed through Medicare Part D for patients on the hospice benefit. Discontinuing non-beneficial medications at end of life has proven to improve patient comfort and quality of life via data published in recent literature. Hospice clinicians can make an impact by framing medication discontinuation discussions therapeutically, clarifying that stopping or adjusting meds is done to prevent harm and promote patient well-being and time them on hospice admission, during changes in level of care and/or when a trust relationship is formed to ease transition.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.2000 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.0000 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.25 Nursing Contact Hours after successfully completing this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.25 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Michigan Board of Nursing
Michigan Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Wyoming Board of Nursing
Wyoming Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.2000 contact hours for participating in this course.
Kansas State Board of Nursing
Kansas State Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Identify common classes of medications appropriate for discontinuation in hospice
Describe communication tactics for discussing medication discontinuation with patients and family members
Recognize benefits and barriers to deprescribing
Outline:
`
Monica Han is a Clinical Sales Specialist at Enclara Pharmacia with 20 years of experience in hospice pharmacy. She graduated from the University of the Sciences in Philadelphia with a Doctorate of Pharmacy degree where she also served as an adjunct professor in Pharmacy Practice. Monica has previously held positions in Operations Management and Clinical Account Management and has provided clinical education to Enclara clients on a variety of topics including end-stage heart failure, pain management, and opioid use and misuse. She is also a BPS Board Certified Geriatric Pharmacist. Disclosure: Monica Han, PharmD, BCGP has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
The target audience for this course is: Nurses; in the following settings: Hospice.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
